Dansk Selskab for Almen Medicin logoDansk Selskab for Almen Medicin logo
Klinisk vejledning

Publiseret: 2019

Type 2-diabetes

Opfølgning og behandling

OBS: Vejledning over 5 år

DSAM tager forbehold for, at der kan være nye retningslinjer/ny evidens på området. Vi har dog valgt at lade vejledningen være aktiv, da der stadig er en del brugbar information i den.

Guidelines

Følgende internationale guidelines er anvendt:

  • American Diabetes Association. Standards of medical care in diabetes-2017 Diabetes Care. 2017;40(Suppl. 1).

  • Helsedirektoratet. Nasjonal faglig retningslinje for diabetes 2017 [Available from: https://helsedirektoratet.no/retningslinjer/diabetes

  • The Royal Australian College of General Practitioners. General practice management of type 2 diabetes: 2016-18 East Melbourne, Vic: RACGP; 2016 [Available from: www.racgp.org.au/download/Documents/Guidelines/Diabetes/2015diabetesmanagement.pdf.

  • International Diabetes Federation. Managing older people with type 2 diabetes global guideline, 2013.

  • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Pharmacologic Managementof Type 2 diabetes:2016 Interim Update, Can J Diabetes 40 (2016) 484–486.

  • NICE guideline [NG28]. Type 2 diabetes in adults: Management /guidance/ng28. Updated 2017

  • Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140–Diabetes og hjertesygdom. NBV, DCS 2016. www.cardio.dk

  • Diabetes og hjertesygdom. NBV, DCS 2016. www.cardio.dk

  • Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A et al. 2013 ESH/ESD guidelines for the management of arterial hypertension. European Heart Journal 2013; 34:2159-2219.

  • Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016;37(39):2999-3058.

  • The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. European Heart Journal 2016; 37:2999–3058.